Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib and Valproic Acid in CML
NCT01011998Phase 2Withdrawn
- Sponsor
- New Mexico Cancer Research Alliance
- Start
- Sep 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valproic acid in chronic myelogenous leukemia (CML), sponsored by New Mexico Cancer Research Alliance. Planned start Sep 2009; status: withdrawn.
02
Drugs
valproic acid
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on NCT01011998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01011998.